Frailty as an INstrument for Evaluation of Elderly Patients With Non ST Elevation Myocardial Infarction (NSTEMI)
NCT ID: NCT01049997
Last Updated: 2015-03-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
307 participants
OBSERVATIONAL
2009-10-31
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Management and Outcomes of Patients Admitted to Coronary Care Units, Depending on Degree of Frailty and Comorbidities
NCT04488536
Myocardial Contrast Echocardiography for the Assessment of the Infarct Related Artery & Risk Area in Patients w/ NSTEMI.
NCT02014701
Coronary CT Angiography in Non ST-elevation Myocardial Infarction
NCT04537741
Cardiac MRI Prior to Invasive Coronary Angiography in Patients With Suspected Non-ST-Elevation Myocardial Infarction
NCT06566625
Myocardial Ischemia in Non-obstructive Coronary Artery Disease
NCT01853527
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NSTEMI75+
Patients, 75 years old or older, with Non ST Elevation Myocardial Infarction (NSTEMI)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Non-evaluable patient due to communication problems and insufficient clinical information for the judgement of frailty (CFS).
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical Research Council
OTHER_GOV
Linkoeping University
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Niklas Ekerstad
MD,PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Niklas G Ekerstad, MD
Role: PRINCIPAL_INVESTIGATOR
Linkoeping University, Sandbäcksgatan 7, 58183 Linkoeping, Sweden
Joakim Alfredsson, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Cardiology, University Hospital of Linkoeping, 58183 Linkoeping, Sweden
Marcus Lindenberger, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Cardiology, County Hospital Ryhov, 551 85 Joenkoeping, Sweden
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Center for Medical Technology Assessment/IMH, Linkoeping University
Linköping, Östergötland County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FINE75+
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.